Physician profile
Khaled Alshabani
NPI 1295099893
$13,364.43
in general payments reported to CMS, 2019-2025
12 companies · $82.11 in 2025
The $82.11 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $45.03 · 2021: $58.67 · 2022: $294 · 2023: $194 · 2024: $13K · 2025: $82.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $13K · Food and Beverage: $411 · Travel and Lodging: $55.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $12,500.00 |
| Food and Beverage | $410.71 |
| Travel and Lodging | $55.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12,600.38 | 2024 | |
| Pinnacle Biologics, INC | $180.99 | 2023-2024 | Photofrin |
| Pulmonx Corporation | $146.40 | 2022 | |
| Erbe USA INC | $97.28 | 2022 | |
| Verona Pharma, INC. | $82.11 | 2025 | Ohtuvayre |
| Steris Corporation | $59.62 | 2023 | |
| Medtronic, INC. | $43.42 | 2023 | Illumisite |
| Regeneron Healthcare Solutions, INC. | $43.28 | 2021-2022 | |
| Genzyme Corporation | $34.13 | 2020-2022 | |
| Insmed, INC. | $31.66 | 2021 | |
| Glaxosmithkline, LLC. | $25.92 | 2020 | |
| Intuitive Surgical, INC. | $19.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khaled Alshabani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.